ALL vs PPCB · P/E 4.9, $56.89B cap vs P/E 0.0, $3.9M cap
The Allstate Corporation (ALL) versus Propanc Biopharma, Inc. Common Stock (PPCB) — a side-by-side from cached financials, not a winner call.
The Allstate Corporation (ALL) is a insurance - property & casualty company listed on US.
Propanc Biopharma, Inc. Common Stock (PPCB) is a biotechnology company listed on NASDAQ.
ALL does not have a complete income-statement cache yet.
PPCB does not have a complete income-statement cache yet.
ALL currently screens at market cap $56.89B and trailing P/E 4.9. PPCB currently screens at market cap $3.9M and trailing P/E 0.0.
Not investment advice. Open the ALL and PPCB stock pages for the full models.
Not investment advice.